Division of Pediatric Dermatology, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Division of Pediatric Rheumatology (Dermatology), Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Division of Pediatric Dermatology, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
J Am Acad Dermatol. 2014 Nov;71(5):935-40. doi: 10.1016/j.jaad.2014.07.029. Epub 2014 Sep 11.
Visible vascular and pigmentary conditions have a negative impact on children's and adolescents' quality of life (QoL). We sought to quantitate the effect of visible skin anomalies and their camouflage on QoL.
In all, 41 patients, 5 years of age and older, were taught to use cosmetic camouflage. QoL was assessed using the Children's Dermatology Life Quality Index (CDLQI) before and 6 months after the intervention. Satisfaction and use were evaluated after 1 and 6 months.
Baseline QoL scores revealed a small impact of vascular anomalies (CDLQI score 4.2) and a small to moderate effect of pigmentary anomalies (CDLQI score 6.1). Six months after the intervention, QoL improved in the study population as a whole (CDLQI score 5.1 vs 2.1, P<.001), with significant improvements documented for facial lesions and vascular malformations. Cosmetic camouflage was well tolerated and patients with pigmentary anomalies were more likely to continue using the products.
Limitations include small study population, few male patients, cultural influences not addressed, and limited range of conditions.
Children and teenagers with visible vascular and pigmentary anomalies experience an impairment of QoL that is abrogated by introduction to use of cosmetic camouflage.
可见的血管和色素异常会对儿童和青少年的生活质量(QoL)产生负面影响。我们旨在定量评估可见皮肤异常及其掩饰对 QoL 的影响。
共纳入 41 名年龄在 5 岁及以上的患者,对他们进行了化妆品遮瑕的使用培训。干预前和干预后 6 个月采用儿童皮肤病生活质量指数(CDLQI)评估 QoL。在 1 个月和 6 个月后评估满意度和使用情况。
基线 QoL 评分显示血管异常的影响较小(CDLQI 评分 4.2),色素异常的影响为小到中度(CDLQI 评分 6.1)。干预后 6 个月,研究人群的 QoL 整体改善(CDLQI 评分 5.1 比 2.1,P<.001),面部病变和血管畸形的改善有显著统计学意义。化妆品遮瑕的耐受性良好,色素异常患者更有可能继续使用产品。
研究人群规模小、男性患者较少、未涉及文化影响以及条件范围有限。
有可见血管和色素异常的儿童和青少年的 QoL 受损,通过引入化妆品遮瑕可以消除这种影响。